Answers are grounded in this paper and cite their sources.
Retrospective cohort study identifies serum prealbumin levels and lymphocyte percentage as key predictors in low-risk gastric and colorectal cancer patients, indicating safer early discharge paths.
Background Early identification of low-risk patients after curative gastric or colorectal surgery can enable safe, timely discharge. We evaluated two routinely available postoperative markers—serum prealbumin (PA) and lymphocyte percentage (L%)—as a simple rule-out strategy. Methods This is a single-center retrospective cohort study with a temporal external validation set. Prealbumin (mg/dL) and L% (%) were measured on postoperative day (POD)1/3/5. We prespecified a high-sensitivity threshold (sensitivity ≥90%) in the training cohort and assessed its performance in the validation cohort. Multivariable logistic models were fitted at POD3 and POD5. Results Postoperative day 1 L% showed limited discrimination; analyses focused on POD3/5. At both time points, PA and L% were independent protective predictors, with no effect modification by tumor site. Slim (PA + L%) and Full models had similar discrimination; both were well calibrated, and decision-curve analysis indicated clear net benefit over default strategies. Under the fixed high-sensitivity approach, the POD3 Slim model maintained high sensitivity and NPV with moderate specificity. Conclusions By POD3, combining PA and L% provides a low-cost, readily deployable, rule-out-oriented approach that supports safe early discharge within structured postoperative pathways. Multicenter prospective validation and impact studies are warranted.
No takes yet. Share an insight, caveat, or question.
A 2025 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: